(69 days)
The HARMONIC ACE® Shears + Adaptive Tissue Technology are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instruments can be used as an adjunct to or substitute for electrosurgery, lasers and steel scalpels in general, plastic, pediatric, gynecologic, urologic, exposure to orthopedic structures (such as spine and joint space) and other open and endoscopic procedures.
The Ethicon Endo-Surgery HARMONIC ACE® Shears + Adaptive Tissue Technology are used for coagulation and mechanical transection of soft tissue during laparoscopic and open procedures. The devices allow the surgeon to grasp, coagulate, and transect soft tissue with a single instrument. The devices are hand-actuated with a shaft and tissue effector that can be rotated. The energy delivery can be activated with hand activation or with an optional generator foot switch.
The provided document describes the HARMONIC ACE® Shears + Adaptive Tissue Technology, an ultrasonic surgical instrument. However, the document primarily focuses on demonstrating substantial equivalence to a predicate device through bench testing and animal model evaluations. It does not contain the specific information requested in your prompt regarding acceptance criteria, a detailed study proving performance against those criteria, or the specific breakdown of data provenance, expert involvement, and MRMC studies you've asked for in the context of an AI/algorithm-based device study.
Therefore, I cannot extract the information to fulfill your request in the format you've provided. The document describes a traditional medical device (surgical shears), not a device involving AI or machine learning algorithms that would typically require the types of studies and acceptance criteria you've outlined for "device performance" in that context.
Summary of what can be extracted from the provided text, relevant to performance but not fitting your requested table format directly (as it's not an AI device):
- Device: HARMONIC ACE® Shears + Adaptive Tissue Technology
- Purpose: Coagulation and mechanical transection of soft tissue; soft tissue incisions where bleeding control and minimal thermal injury are desired.
- Performance Claim: As safe and effective and perform as well as the legally marketed predicate devices for cutting and coagulating soft tissue and sealing vessels up to 5 mm in diameter, as measured in situ.
- Studies Conducted:
- Bench testing
- Laboratory evaluations in an animal model (acute and 30-day chronic survival studies)
- Conclusion: These studies demonstrate the device performs as intended and is equivalent to the predicate device.
To reiterate, the document does not provide the following information from your request:
- A table of acceptance criteria and the reported device performance in the context of AI/algorithm metrics (e.g., sensitivity, specificity, AUC).
- Sample size used for the test set and data provenance.
- Number of experts and their qualifications for ground truth establishment.
- Adjudication method for the test set.
- MRMC comparative effectiveness study results or effect size of AI assistance.
- Standalone (algorithm-only) performance results.
- Type of ground truth (e.g., pathology, outcomes data).
- Sample size for the training set.
- How ground truth for the training set was established.
{0}------------------------------------------------
K120729
510(k) Summary of Safety and Effectiveness
- Company Ethicon Endo-Surgery, LLC 475 Calle C Guaynabo, PR 00969
- Contact Donovan May Regulatory Affairs Associate II Ethicon Endo-Surgery, Inc. Telephone: (513) 337-7981 Fax: (513) 337-2793 Email: dmay3@its.jnj.com
Date Prepared March 8. 2012
Device Name Trade Name: HARMONIC ACE® Shears + Adaptive Tissue Technology Common Name: Instrument, Ultrasonic Surgical
Classification Name
Instrument, Ultrasonic Surgical (Unassigned, Product Code LFL)
Predicate Device
Harmonic ACE® Curved Shears with Pistol Handle and Hand Control cleared under K060245 on April 7. 2006
Device Description:
The Ethicon Endo-Surgery HARMONIC ACE® Shears + Adaptive Tissue Technology are used for coagulation and mechanical transection of soft tissue during laparoscopic and open procedures. The devices allow the surgeon to grasp, coagulate, and transect soft tissue with a single instrument. The devices are hand-actuated with a shaft and tissue effector that can be rotated. The energy delivery can be activated with hand activation or with an optional generator foot switch.
Indications for Use:
The HARMONIC ACE® Shears + Adaptive Tissue Technology are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instruments can be used as an adjunct to or substitute for electrosurgery, lasers and steel scalpels in general, plastic, pediatric, gynecologic, urologic, exposure to orthopedic structures (such as spine and joint space) and other open and endoscopic procedures.
{1}------------------------------------------------
Technological Characteristics: The Ethicon Endo-Surgery HARMONIC ACE® Shears + . Adaptive Tissue Technology incorporate most of the same technological characteristics as that of the predicate devices with an ergonomic handle and redesigned blade geometry. Additionally, a change was made to several patient contacting materials with respect to the subject devices including the addition of a coating to the ultrasonic blade and a new pad material. The control mechanism was changed from a resistor identification to an EEPROM memory chip that stores device identification, usage tracking, and operating parameters for use by the Generator G11 that provides power for the HARMONIC ACE® Shears + Adaptive Tissue Technology.
Adaptive Tissue Technology refers to the power output algorithm that is utilized by the devices. During use, the Adaptive Tissue Technology algorithm parameters stored on the device EEPROM are read by the generator and used to reduce the power (current) to the instrument and provide a secondary, higher pitched generator activation tone when there is little or no tissue between the instrument blade and tissue pads. To do this the generator monitors the thermal condition of the blade during device activation.
Performance Data: Bench testing and laboratory evaluations in an animal model including acute and 30-day chronic survival studies were conducted to demonstrate that the HARMONIC ACE® Shears + Adaptive Tissue Technology perform as intended.
Conclusion: The results of the bench top and animal model testing demonstrate that the HARMONIC ACE® Shears + Adaptive Tissue Technology are as safe and effective and perform as well as the identified legally marketed predicate devices for cutting and coagulating soft tissue and sealing vessels up to 5 mm in diameter, as measured in situ.
2/2
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" around the perimeter. In the center of the circle is an abstract image of an eagle.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
MAY 1 7 2012
Ethicon Endo-Surgery, LLC % Ethicon Endo-Surgery, Inc. Mr. Donovan May 4545 Creek Road Cincinnati, Ohio 45242
Re: K120729
Trade/Device Name: HARMONIC ACE® Shears + Adaptive Tissue Technology Regulatory Class: Unclassified Product Code: LFL Dated: May 04, 2012 Received: May 07, 2012
Dear Mr. May:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
{3}------------------------------------------------
Page 2 - Mr. Donovan May
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
Indications for Use
{4}------------------------------------------------
Ethicon Endo-Surgery, LLC 510(k)
Indications for Use
K120729 510(k) Number (if known):
Device Name: HARMONIC ACE® Shears + Adaptive Tissue Technology
Indications for Use:
The HARMONIC ACE® Shears + Adaptive Tissue Technology are indicated for soft tissue incisions when bleeding control and minimal thermal injury are desired. The instruments can be used as an adjunct to or substitute for electrosurgery, lasers and steel scalpels in general, plastic, pediatric, gynecologic, urologic, exposure to orthopedic structures (such as spine and joint space) and other open and endoscopic procedures.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Nwf R.P. Ryder for mxm
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
Page 1 of 1
510(k) Number K120729
14
N/A